The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis
Work
Year: 2024
Type: article
Abstract: The serine protease inhibitor SerpinB3 has been described as critical mediator of liver fibrosis and it has been recently proposed as an additional hepatokine involved in NASH development and insulin ... more
Source: Molecular Metabolism
Institutions University of Padua, University of Turin, University of Pavia
Cites: 55
Cited by: 8
Related to: 10
FWCI: 11.06
Citation percentile (by year/subfield): 79.6
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,700